NDC properties for "0.8 ML Cyltezo 50 MG/ML Auto-Injector" (RxCUI 2640898)
About this data
The tables show NDC propoerties for 0.8 ML Cyltezo 50 MG/ML Auto-Injector with the RxCUI 2640898
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Cyltezo 50 MG/ML Auto-Injector (RxCUI 2640898)
| BLA | BLA761058 |
|---|---|
| MMSL_CODE | BD32554 |
| RxCUI | 2640898 |
| SPL_SET_ID | 115ea79b-7209-7f19-b35d-36ec0828fbf5 |
| Prescribable Synonym | CYLTEZO 40 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML Cyltezo 50 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo] |
| RxNorm Synonym | 0.8 ML Cyltezo 50 MG/ML Auto-Injector |
| RxNorm Synonym | Cyltezo 40 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2640898) |
NDC Properties
NDC Item 00597037548
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-48 |
| NDC Item | 00597037548 |
| Packaging | 1 KIT in 1 CARTON (0597-0375-48) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037553
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-53 |
| NDC Item | 00597037553 |
| Packaging | 1 KIT in 1 CARTON (0597-0375-53) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037597
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-97 |
| NDC Item | 00597037597 |
| Packaging | 2 KIT in 1 CARTON (0597-0375-97) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037548
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-48 |
| NDC Item | 00597037548 |
| Packaging | 1 KIT in 1 CARTON (0597-0375-48) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037553
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-53 |
| NDC Item | 00597037553 |
| Packaging | 1 KIT in 1 CARTON (0597-0375-53) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037597
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-97 |
| NDC Item | 00597037597 |
| Packaging | 2 KIT in 1 CARTON (0597-0375-97) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037548
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-48 |
| NDC Item | 00597037548 |
| Packaging | 1 KIT in 1 CARTON (0597-0375-48) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037553
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-53 |
| NDC Item | 00597037553 |
| Packaging | 1 KIT in 1 CARTON (0597-0375-53) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |
NDC Item 00597037597
| NDC 9 | 0597-0375 |
|---|---|
| NDC 10 | 0597-0375-97 |
| NDC Item | 00597037597 |
| Packaging | 2 KIT in 1 CARTON (0597-0375-97) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0375 |